• Profile
Close

Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma

British Journal of Surgery Feb 22, 2019

Almond LM, et al. - Researchers reviewed data on patients with suspected retroperitoneal sarcoma (RPS) who underwent percutaneous biopsy followed by surgical resection 2005-2016 at one of two tertiary European sarcoma units in order to verify the diagnostic accuracy of percutaneous core biopsy with respect to histological diagnosis and tumor grade. They correlated histological tumor type and tumor grade on biopsy with postoperative histology among a total of 239 patients who underwent percutaneous core biopsy followed by surgical resection in Milan (163) or Birmingham (76). They observed variation in diagnostic accuracy with histological diagnosis, but with an overall concordance with final pathology following resection in 67.2% of biopsies. Findings supported the high reliability of a diagnosis of DDLPS or leiomyosarcoma on percutaneous biopsy. Possible identification of high-grade sarcomas with high specificity may allow for a study on neoadjuvant therapy in these patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay